ARCHIVES

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

Sam Broder Receives Arthur Flemming Award

June 1, 1984

Guest Editorial: Learning from the Power Morcellation Fiasco: Government Must Do More to Regulate Devices

September 12, 2014